Alan J. Russell, Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX), sold 96,975 shares at $17.98 ($1.8M) on 2021-09-27, disclosed to the SEC on 2021-09-27.
Open-market sale of $1.8M EWTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.34 | 21,763 | $399K | 22.5% |
| 2 | $18.34 | 21,763 | $399K | 22.5% |
| 3 | $19.42 | 5,072 | $98K | 5.5% |
| 4 | $19.42 | 5,072 | $98K | 5.5% |
| 5 | $18.16 | 20,100 | $365K | 20.5% |
| 6 | $17.98 | 11,594 |
| $208K |
| 11.7% |
| 7 | $17.98 | 11,594 | $208K | 11.7% |
| 8 | $18.48 | 17 | $314 | 0.0% |
| Total | $18.33 avg | 96,975 | $1.8M | 100% |
| Filing → |
| EWTX | SELL | 2025-11-13 | $2.1M | — | Filing → |
| EWTX | SELL | 2025-08-28 | $1.5M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $26K | — | Filing → |